FDA Needs to Explain Why There's No Vaccine for Kids, Says Johns Hopkins

The transcript discusses the rising pediatric hospitalizations due to COVID-19, particularly focusing on the immune response in children. It highlights the challenges in approving vaccines for those under 12 and the need for FDA transparency. The impact of the Delta variant on the pandemic's trajectory is examined, emphasizing the importance of vaccination. The potential for the US to aid in global vaccine distribution and manufacturing is also explored, suggesting opportunities for international partnerships.

How has the Delta variant impacted the situation regarding COVID-19 in the United States?

What role can the United States play in helping other countries with COVID-19 vaccinations?